Double maintains 4 strategies that include CYTK - Cytokinetics, Inc.
Yahoo
SOUTH SAN FRANCISCO, Calif., June 17, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on June 15, 2025 it granted stock options to purchase an aggregate of 83,583 shares of common stock and 56,334 restricted stock units (RSUs) that will be settled in shares of common stock upon vesting to 11 employees, whose employment commenced in May and June, 2025, as a material inducement to their employment. The RSUs will vest over 3 years, with 40% of the RSUs vestin
Yahoo
Cytokinetics, Incorporated (NASDAQ:CYTK) is one of the 13 Biotech Stocks with Huge Upside Potential. Tessa Romero, an analyst at JPMorgan, has maintained her Overweight rating on Cytokinetics, Incorporated (NASDAQ:CYTK) but reduced the firm’s price objective from $71 to $53. Aficamten’s revised revenue projections, which anticipate a slower launch trajectory, are the basis for the modification. […]
Yahoo
Program to Provide Donations to Non-Profit Organizations Aligned with Corporate Values Deadline for Applications is August 4th, 2025 SOUTH SAN FRANCISCO, Calif., June 10, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced a call for proposals for its annual Cytokinetics Corporate Giving Program. The program provides charitable donations to eligible non-profit organizations in the United States to support equitable healthcare initiatives for cardiovascular disease,
Yahoo
Cytokinetics (CYTK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Yahoo
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025 at 9:20 AM Eastern Time at the New York Marriott Marquis Hotel in New York, NY. Interested parties may access the live webcast of the fireside chat by visiting the Investors & Media section of the Cytokinetics web
SeekingAlpha
Bristol-Myers Squibb's financial position improved, it raised both its EPS guidance and revenue expectations, and Opdivo's received approval. Read why BMY earns a Strong Buy upgrade.
Current Value
$32.811 Year Return
Current Value
$32.811 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 59.45% | $4.66B | 0.35% |
IBB | 53.26% | $5.44B | 0.45% |
GNOM | 50.62% | $43.17M | 0.5% |
PBE | 48.60% | $222.71M | 0.58% |
BBH | 47.21% | $336.53M | 0.35% |
PTH | 46.15% | $101.31M | 0.6% |
PINK | 45.83% | $131.33M | 0.5% |
ARKG | 44.79% | $1.02B | 0.75% |
FBT | 44.13% | $997.89M | 0.54% |
FHLC | 41.09% | $2.42B | 0.084% |
VHT | 40.74% | $15.27B | 0.09% |
KJUL | 39.68% | $117.87M | 0.79% |
IWO | 39.53% | $11.30B | 0.24% |
FXH | 39.13% | $892.55M | 0.62% |
VTWO | 38.26% | $12.19B | 0.07% |
IWM | 38.24% | $62.96B | 0.19% |
IYH | 37.80% | $2.76B | 0.39% |
IWC | 37.59% | $801.78M | 0.6% |
ISCG | 37.57% | $662.94M | 0.06% |
RYLD | 37.35% | $1.30B | 0.6% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SHYM | -0.05% | $329.29M | 0.35% |
IBTH | -0.13% | $1.58B | 0.07% |
SPTS | -0.34% | $5.74B | 0.03% |
FMF | 0.36% | $156.61M | 0.95% |
SCHO | 0.69% | $10.92B | 0.03% |
UTWO | 0.76% | $372.79M | 0.15% |
UNG | 1.04% | $373.15M | 1.06% |
XHLF | -1.11% | $1.72B | 0.03% |
SPSK | -1.20% | $315.10M | 0.5% |
WEAT | -1.24% | $122.67M | 0.28% |
GOVT | 1.47% | $27.17B | 0.05% |
TPMN | -1.50% | $30.91M | 0.65% |
BSCP | 1.64% | $3.34B | 0.1% |
VGSH | 1.86% | $22.55B | 0.03% |
BUXX | -2.06% | $309.56M | 0.25% |
BIL | 2.38% | $43.95B | 0.1356% |
JMST | -2.64% | $4.00B | 0.18% |
GOVZ | 2.68% | $256.77M | 0.1% |
AGZD | 2.70% | $111.91M | 0.23% |
GBIL | -2.71% | $6.38B | 0.12% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IMVT | 48.73% | $2.71B | -39.44% | 0.00% |
IDYA | 47.16% | $1.91B | -41.35% | 0.00% |
KRYS | 45.60% | $3.82B | -23.65% | 0.00% |
DNLI | 44.45% | $2.05B | -31.67% | 0.00% |
ROIV | 44.11% | $7.78B | +5.54% | 0.00% |
ACLX | 43.17% | $3.52B | +18.60% | 0.00% |
BEAM | 43.02% | $1.71B | -26.67% | 0.00% |
EYPT | 42.33% | $613.80M | +2.65% | 0.00% |
CRNX | 41.69% | $2.86B | -31.14% | 0.00% |
IMNM | 40.91% | $768.32M | -33.51% | 0.00% |
NTLA | 40.48% | $994.40M | -61.29% | 0.00% |
ABCL | 40.19% | $1.04B | +14.90% | 0.00% |
ZYME | 39.72% | $887.30M | +48.24% | 0.00% |
OCUL | 39.71% | $1.33B | +51.73% | 0.00% |
CGON | 39.43% | $2.00B | -22.46% | 0.00% |
XENE | 39.38% | $2.45B | -12.00% | 0.00% |
BBIO | 39.31% | $7.60B | +44.88% | 0.00% |
NUVL | 39.27% | $5.42B | -3.29% | 0.00% |
ARQT | 39.21% | $1.63B | +67.73% | 0.00% |
IONS | 39.14% | $5.89B | -8.93% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -32.72% | $185.08M | 0.85% |
TAIL | -27.57% | $101.78M | 0.59% |
BTAL | -21.26% | $291.48M | 1.43% |
USDU | -10.52% | $164.82M | 0.5% |
ULST | -9.46% | $668.01M | 0.2% |
FTSD | -8.03% | $228.56M | 0.25% |
UUP | -7.64% | $197.14M | 0.77% |
TFLO | -7.15% | $6.92B | 0.15% |
IVOL | -6.90% | $349.05M | 1.02% |
KMLM | -6.26% | $186.03M | 0.9% |
FXY | -5.93% | $853.67M | 0.4% |
XONE | -5.03% | $640.90M | 0.03% |
STOT | -4.56% | $248.21M | 0.45% |
CLIP | -4.13% | $1.51B | 0.07% |
IBTG | -4.07% | $1.96B | 0.07% |
CTA | -3.44% | $1.09B | 0.76% |
GBIL | -2.71% | $6.38B | 0.12% |
JMST | -2.64% | $4.00B | 0.18% |
BUXX | -2.06% | $309.56M | 0.25% |
TPMN | -1.50% | $30.91M | 0.65% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -15.25% | $23.83B | +34.36% | 1.10% |
LITB | -10.86% | $22.07M | -76.50% | 0.00% |
K | -9.78% | $27.39B | +34.25% | 2.89% |
FMTO | -9.71% | $4.80K | -99.92% | 0.00% |
CCEC | -7.59% | $1.02B | +3.91% | 2.58% |
MNOV | -7.20% | $62.29M | -3.05% | 0.00% |
CORT | -6.15% | $7.55B | +153.07% | 0.00% |
BTCT | -6.04% | $19.62M | +36.77% | 0.00% |
DFDV | -4.84% | $460.68M | +2,996.21% | 0.00% |
PPC | -4.79% | $10.88B | +45.80% | 0.00% |
CPS | -4.34% | $368.16M | +75.71% | 0.00% |
PG | -3.21% | $370.48B | -6.25% | 2.58% |
CME | -2.88% | $98.05B | +38.45% | 3.91% |
LRN | -2.82% | $6.31B | +108.52% | 0.00% |
VSA | -2.78% | $8.84M | -14.05% | 0.00% |
LFVN | -2.26% | $158.99M | +88.79% | 1.31% |
TPB | -1.93% | $1.33B | +129.02% | 0.29% |
OXBR | -1.84% | $12.58M | -29.29% | 0.00% |
ASPS | -1.55% | $111.52M | -23.08% | 0.00% |
CNK | -1.45% | $3.76B | +65.32% | 0.49% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CHD | -0.19% | $23.62B | -12.76% | 1.21% |
FCN | -0.20% | $5.53B | -22.46% | 0.00% |
TR | -0.24% | $2.47B | +22.26% | 1.33% |
KNOP | 0.30% | $233.22M | -2.16% | 1.52% |
CARV | 0.33% | $8.64M | +4.32% | 0.00% |
DXCM | 0.39% | $31.76B | -30.55% | 0.00% |
HLN | -0.49% | $47.01B | +23.52% | 1.69% |
MCK | 0.67% | $91.20B | +20.89% | 0.39% |
TRUP | 0.74% | $2.34B | +97.44% | 0.00% |
AIFU | 0.86% | $4.18B | +24.38% | 0.00% |
QXO | -0.87% | $13.01B | -75.48% | 0.00% |
CALM | 0.91% | $5.49B | +74.90% | 6.53% |
PM | 0.94% | $284.24B | +80.37% | 2.94% |
CL | 1.00% | $71.47B | -9.09% | 2.29% |
GALT | -1.01% | $208.23M | +41.20% | 0.00% |
PRDO | 1.10% | $2.12B | +56.80% | 1.60% |
MO | 1.19% | $100.21B | +32.79% | 6.87% |
CYCN | -1.20% | $10.11M | +42.53% | 0.00% |
KMB | 1.20% | $42.46B | -9.68% | 3.87% |
TKC | -1.23% | $5.10B | -20.73% | 3.52% |